삼성바이오로직스

207940 코스피
1,419,000 30,000 (-2.07%)
기준 : 05/15
  • 시가총액
    656,869억
  • 주식수
    4,629만
  • PER
    36.81배
  • PBR
    8.82배
  • ROE
    23.95%
  • 결산월
    12월

26.1Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2026/03 2025/12 2025/09 2025/06 2025/03 2024/12 2024/09 2024/06 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09 2019/06 2019/03 2018/12 2018/09 2018/06 2018/03 2017/12 2017/09 2017/06 2017/03 2016/12 2016/09 2016/06 2016/03 2015/12 2015/09 2015/06 2015/03 2014/12 2014/09 2014/06 2014/03 2013/12 2013/09 2013/06 2013/03 2012/12 2012/09
매출액(수익) 54,92954,929.5 45,56945,569.7 44,54644,546.6 39,81539,815.1 38,48538,485.1
내수 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 45,56945,569.7 44,54644,546.6 39,81539,815.1 38,48538,485.1
매출원가 N/AN/A 20,40320,403.3 19,34919,349.1 18,96418,964.9 18,24618,246.4
원재료 N/AN/A 8,9738,973.2 8,8368,836.0 8,8518,851.2 8,0428,042.4
재고자산의변동 N/AN/A -2,157-2,157.6 -3,028-3,028.3 -2,977-2,977.4 -2,624-2,624.3
기타원가 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
인건비 N/AN/A 5,5935,593.6 5,4265,426.1 5,2155,215.3 5,0565,056.5
감가상각비 N/AN/A 3,2773,277.0 3,3193,319.0 3,0673,067.2 2,7912,791.8
기타 N/AN/A 4,7174,717.0 4,7964,796.2 4,8084,808.5 4,9804,980.0
매출총이익 N/AN/A 25,16625,166.4 25,19725,197.5 20,85020,850.1 20,23820,238.6
판매비와관리비 N/AN/A 4,4744,474.1 5,0165,016.3 4,5714,571.7 4,3714,371.1
급여 N/AN/A 1,4561,456.7 1,3201,320.5 1,1771,177.3 1,0341,034.2
퇴직급여 N/AN/A 7676.0 7878.1 7070.8 6161.8
복리후생비 N/AN/A 343343.4 335335.1 284284.1 253253.0
임차료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수도광열비 N/AN/A 1919.9 1818.5 1717.8 1717.3
전산처리비 N/AN/A 119119.5 338338.4 329329.3 328328.7
지급수수료 N/AN/A 1,0251,025.3 1,2211,221.1 1,1111,111.9 1,1371,137.9
용역비 N/AN/A N/AN/A 22.0 33.6 55.3
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 6666.1 6666.5 5555.1 6666.6
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 371371.8 658658.1 611611.5 474474.0
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A -8-8.1 -42-42.1 -122-122.1 -10-10.9
감가상각비 N/AN/A 182182.2 173173.5 209209.4 193193.4
무형자산상각비 N/AN/A 137137.9 137137.0 127127.7 115115.7
기타 N/AN/A 683683.0 709709.2 695695.0 693693.6
영업이익 23,13423,134.5 20,69220,692.2 20,18120,181.1 16,27816,278.4 15,86715,867.5
EBITDA N/AN/A 27,35427,354.0 27,29227,292.6 22,22122,221.9 22,45922,459.7
금융손익 N/AN/A 9494.1 258258.8 -572-572.9 415415.8
금융수익 N/AN/A 1,5071,507.8 1,7331,733.8 1,5541,554.7 1,9431,943.8
이자수익 N/AN/A 460460.3 432432.2 432432.0 452452.4
외환거래이익 N/AN/A 1,0471,047.4 1,2871,287.7 1,1241,124.8 1,4931,493.8
외환차익 N/AN/A 949949.0 945945.1 1,1441,144.4 1,1821,182.6
외화환산이익 N/AN/A 9898.4 342342.6 -19-19.6 311311.1
기타 N/AN/A 00.0 00.0 00.0 N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가이익 N/AN/A N/AN/A 55.3 77.5 N/AN/A
파생상품이익 N/AN/A 00.0 88.5 -9-9.7 -2-2.4
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 N/AN/A 1,4131,413.6 1,4741,474.9 2,1272,127.6 1,5281,528.0
이자비용 N/AN/A 291291.7 370370.2 280280.3 279279.5
외환거래손실 N/AN/A 1,1211,121.9 1,1361,136.5 1,8801,880.5 1,2611,261.9
외환차손 N/AN/A 968968.8 1,0771,077.8 1,3111,311.6 1,4461,446.3
외화환산손실 N/AN/A 153153.0 5858.7 568568.8 -184-184.4
기타 N/AN/A 00.0 00.0 N/AN/A 00.0
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A -31-31.8 -33-33.3 -13-13.3
기타 N/AN/A 00.0 00.0 00.0 00.0
기타영업외손익 N/AN/A -30-30.9 2020.3 -8-8.0 -28-28.5
기타영업외수익 N/AN/A 7272.8 100100.3 6969.3 5151.5
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A 00.0 00.0 00.0 00.0
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A 55.9 55.8 55.9 55.8
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A 88.1 88.4 99.7 88.3
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 5858.7 8585.9 5353.6 3737.3
기타영업외비용 N/AN/A 103103.8 8080.0 7777.4 8080.0
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A 4040.6 3636.9 3838.2 3737.2
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 6262.5 3232.1 2828.2 3131.9
무형자산처분손실 N/AN/A 00.0 00.0 00.0 00.0
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A N/AN/A 66.8 66.8 66.8
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.5 44.1 44.0 33.9
종속기업및관계기업관련손익 N/AN/A 430430.8 180180.9 183183.7 186186.8
지분법손익 N/AN/A 430430.8 180180.9 183183.7 186186.8
지분법이익 N/AN/A 430430.8 179179.0 180180.7 185185.6
지분법손실 N/AN/A N/AN/A 11.8 22.9 11.2
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A 11.8 183183.7 186186.8
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 N/AN/A 21,18621,186.3 20,64120,641.2 15,88115,881.2 16,44116,441.7
법인세비용 N/AN/A 5,0435,043.0 5,1125,112.4 3,4523,452.3 4,0764,076.8
중단사업이익 N/AN/A 1,7001,700.2 430430.1 430430.1 430430.1
당기순이익 18,21118,211.4 17,84317,843.5 15,95815,958.9 12,85912,859.0 12,79512,795.0
지배지분 순이익 N/AN/A 17,84317,843.5 15,95815,958.9 12,85912,859.0 12,79512,795.0
비지배지분 순이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익 N/AN/A -53-53.9 -80-80.2 -114-114.3 -96-96.3
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
해외사업환산손익 N/AN/A 0-0.9 3535.2 11.4 1919.4
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A -52-52.9 -115-115.4 -115-115.8 -115-115.8
총포괄이익 N/AN/A 17,78917,789.5 15,87815,878.6 12,74412,744.7 12,69812,698.7
지배지분 총포괄이익 N/AN/A 17,78917,789.5 15,87815,878.6 12,74412,744.7 12,69812,698.7
비지배지분 총포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
주당순이익 N/AN/A 27,14027,140.9 22,42222,422.4 18,06718,067.0 17,97717,977.1
시가총액 N/AN/A 784,631784,631.6 709,604709,604.7 706,046706,046.0 721,704721,704.3
주가 N/AN/A 1,695,0001,695,000.0 1,467,3291,467,329.0 1,459,9701,459,970.0 1,492,3481,492,348.0
주가수익배수 N/AN/A 43.9743.97 44.4644.46 54.9154.91 56.4056.40
주식수(만주) N/A 4,629 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 7,117 6,696 6,696 6,696 6,696 6,696 6,696 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

20년 재무제표를 한번에! 프리미엄 서비스를 무제한으로 이용하세요. 프리미엄 55% 평생할인

밸류라인 서비스를 무제한 이용하세요 프리미엄